Trial NCT00022490

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000068822
Secondary IDs: NCI-4653 OHSU-1184 OHSU-HEM-01017-LX OHSU-NCI-4653

Last trial update was posted on 2016-01-07

MeSH Interventions

Cytarabine Imatinib Mesylate

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

Study was terminated, therefore the 12 month response data was not analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID